journal article
Open Access
Sep 14, 2021
Night Vision and Carotenoids (NVC): A Randomized Placebo Controlled Clinical Trial on Effects of Carotenoid Supplementation on Night Vision in Older Adults
Abstract
Twilight and low luminance levels are visually challenging environments for the elderly, especially when driving at night. Carotenoid rich diets are known to increase macular pigment optical density (MPOD), which in turn leads to an improvement in visual function. It is not known whether augmenting MPOD can lead to a decrease in vision related night driving difficulties. Additionally, it is unknown if carotenoid supplementation provides additional measurable benefits to one’s useful field of view (UFOV) along with a decreased composite crash risk score. The aim of the study was to evaluate changes in night vision function and UFOV in individuals that took carotenoid vitamin supplements for a six-month period compared to a placebo group. Methods: A prospective, randomized, double-blind, six-month trial of a 14 mg zeaxanthin/7 mg lutein-based supplement was carried out. Participants were randomized into active or placebo group (approx 2:1). Results: n = 33 participants (26 males/7 females) participated with 93% capsule intake compliance in the supplemented group (n = 24) and placebo group (n = 9). MPOD (mean/standard error SE) in the active group increased in the Right eye from 0.35 density units (du)/0.04 SE to 0.41 du/0.05 SE; p < 0.001 and in the Left eye from 0.35 du/0.05 SE to 0.37 du, p > 0.05). The supplemented group showed significant improvements in contrast sensitivity with glare in both eyes with improvements in LogMAR scores of 0.147 and 0.149, respectively (p = 0.02 and 0.01, respectively), monocularly tested glare recovery time improved 2.76 and 2.54 s, respectively, (p = 0.008 and p = 0.02), and we also noted a decreased preferred luminance required to complete visual tasks (p = 0.02 and 0.03). Improvements in UFOV scores of divided attention (p < 0.001) and improved composite crash risk score (p = 0.004) were seen in the supplemented group. The placebo group remained unchanged. Conclusions: The NVC demonstrates that augmenting MPOD in individuals with difficulty in night vision showed measurable benefits in numerous visual functions that are important for night vision driving in this small sample RCT. Additionally, we observed an improvement in UFOV divided attention test scores and decreased composite risk scores.
Topics
No keywords indexed for this article. Browse by subject →
References
52
[1]
Andysz "Visual abilities of older drivers—Review of driving simulator studies" Med. Pr. (2012)
[2]
(2021, March 16). Prevalence of Impairments of Visual Function among European Drivers—Vision Impact Institute. Available online: https://www.visionimpactinstitute.org/research/prevalence-of-impairments-of-visual-function-among-european-drivers.
[3]
Nischler "Prevalence of impairment of visual function in European drivers" Acta Ophthalmol. (2011) 10.1111/j.1755-3768.2009.01640.x
[4]
Hessburg, P.C. (2002, January 7–8). Autonomous Vehicles, Drivers Fitness to Function and Naturalistic Driving Methods. Proceedings of the 9th World Congress on Health and Modern Mobility, Detroit, MI, USA. Available online: www.henryford.com/TheEyeAndTheAuto.
[5]
Wood "Effects of Age-Related Macular Degeneration on Driving Performance" Investig. Opthalmol. Vis. Sci. (2018) 10.1167/iovs.17-22751
[6]
(2021, March 27). NHTSA Report, Available online: https://one.nhtsa.gov/nhtsa/whatis/planning/2020Report/2020report.html.
[7]
Chew "Secondary Analyses of the Effects of Lutein/Zeaxanthin on Age-Related Macular Degeneration Progression" JAMA Ophthalmol. (2014) 10.1001/jamaophthalmol.2013.7376
[8]
Carroll "A European carotenoid database to assess carotenoid intakes and its use in a five-country comparative study" Br. J. Nutr. (2001) 10.1079/bjn2000284
[9]
Richer "Macular Re-pigmentation Enhances Driving Vision in Elderly Adult Males with Macular Degeneration" J. Clin. Exp. Ophthalmol. (2012) 10.4172/2155-9570.1000217
[10]
Yao "Lutein supplementation improves visual performance in Chinese drivers: 1-year randomized, double-blind, placebo-controlled study" Nutrition (2013) 10.1016/j.nut.2012.10.017
[11]
Arunkumar "What do we know about the macular pigment in AMD: The past, the present, and the future" Eye (2018) 10.1038/s41433-018-0044-0
[12]
Hammond "Glare Disability, Photostress Recovery, and Chromatic Contrast: Relation to Macular Pigment and Serum Lutein and Zeaxanthin" Investig. Opthalmol. Vis. Sci. (2013) 10.1167/iovs.12-10411
[13]
Owsley "A roadmap for interpreting the literature on vision and driving" Surv. Ophthalmol. (2015) 10.1016/j.survophthal.2015.01.005
[14]
Stringham "Macular Pigment and Visual Performance in Glare: Benefits for Photostress Recovery, Disability Glare, and Visual Discomfort" Investig. Opthalmol. Vis. Sci. (2011) 10.1167/iovs.10-6699
[15]
Oliver "Neural Activation During Visual Attention Differs in Individuals with High versus Low Macular Pigment Density" Mol. Nutr. Food Res. (2019) 10.1002/mnfr.201801052
[16]
Kaido "Aged Drivers May Experience Decreased Visual Function While Driving" Asia-Pac. J. Ophthalmol. (2013) 10.1097/apo.0b013e3182897e4d
[17]
Johnson "Relationship between Serum and Brain Carotenoids,α-Tocopherol, and Retinol Concentrations and Cognitive Performance in the Oldest Old from the Georgia Centenarian Study" J. Aging Res. (2013) 10.1155/2013/951786
[18]
Vishwanathan "Macular pigment carotenoids in the retina and occipital cortex are related in humans" Nutr. Neurosci. (2016) 10.1179/1476830514y.0000000141
[19]
Feeney "Low macular pigment optical density is associated with lower cognitive performance in a large, population-based sample of older adults" Neurobiol. Aging (2013) 10.1016/j.neurobiolaging.2013.05.007
[20]
Hoffmann "A Prospective Study of Neuro-Cognitive Enhancement with Carotenoids in Elderly Adult Males with Early Age Related Macular Degeneration" Ophthalmol. Res. Int. J. (2015) 10.9734/or/2015/17131
[21]
Bernstein "The value of measurement of macular carotenoid pigment optical densities and distributions in age-related macular degeneration and other retinal disorders" Vis. Res. (2010) 10.1016/j.visres.2009.10.014
[22]
Davey, P.G., Henderson, T., Lem, D.W., Weis, R., Amonoo-Monney, S., and Evans, D.W. (2020). Visual Function and Macular Carotenoid Changes in Eyes with Retinal Drusen—An Open Label Randomized Controlled Trial to Compare a Micronized Lipid-Based Carotenoid Liquid Supplementation and AREDS-2 Formula. Nutrients, 12.
10.3390/nu12113271
[23]
Lem, D.W., Davey, P.G., Gierhart, D.L., and Rosen, R.B. (2021). A Systematic Review of Carotenoids in the Management of Age-Related Macular Degeneration. Antioxidants, 10.
10.3390/antiox10081255
[24]
Lem, D.W., Gierhart, D.L., and Davey, P.G. (2021). Carotenoids in the Management of Glaucoma: A Systematic Review of the Evidence. Nutrients, 13.
10.3390/nu13061949
[25]
Lem, D.W., Gierhart, D.L., and Davey, P.G. (2021). A Systematic Review of Carotenoids in the Management of Diabetic Retinopathy. Nutrients, 13.
10.3390/nu13072441
[26]
Richer "Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: The Veterans LAST study (Lutein Antioxidant Supplementation Trial)" Optometry (2004) 10.1016/s1529-1839(04)70049-4
[27]
Richer "Randomized, double-blind, placebo-controlled study of zeaxanthin and visual function in patients with atrophic age-related macular degeneration" Optom. J. Am. Optom. Assoc. (2011)
[28]
Owsley "Development of a Questionnaire to Assess Vision Problems under Low Luminance in Age-Related Maculopathy" Investig. Opthalmol. Vis. Sci. (2006) 10.1167/iovs.05-1222
[29]
Richer "Predicting night vision difficulties during an eye examination. (Night Vision & Carotenoids RCT; Hines VA IRB 1052607-1, Baseline Data)" Investig. Ophthalmol. Vis. Sci. (2019)
[30]
Jackson "Diagnostic Sensitivity and Specificity of Dark Adaptometry for Detection of Age-Related Macular Degeneration" Investig. Opthalmol. Vis. Sci. (2014) 10.1167/iovs.13-13745
[31]
(2021, March 16). Intelligent Refractor RT-6100. Available online: https://www.nidek-intl.com/product/ophthaloptom/refraction/ref_optometry/rt-6100.html.
[32]
(2021, March 16). Smart System Standard. Available online: https://premierop.com/smart-system-standard/.
[33]
Davey "Macular pigment optical density: Repeatability, intereye correlation, and effect of ocular dominance" Clin. Ophthalmol. (2016) 10.2147/opth.s111708
[34]
Berendschot "A new desktop instrument for measuring macular pigment optical density based on a novel technique for setting flicker thresholds" Ophthalmic Physiol. Opt. (2009) 10.1111/j.1475-1313.2008.00618.x
[35]
Davey, P.G., Rosen, R.B., and Gierhart, D.L. (2021). Macular Pigment Reflectometry: Developing Clinical Protocols, Comparison with Heterochromatic Flicker Photometry and Individual Carotenoid Levels. Nutrients, 13.
10.3390/nu13082553
[36]
Sanabria "Measurement of Carotenoids in Perifovea using the Macular Pigment Reflectometer" J. Vis. Exp. (2020)
[37]
Srinivasan "Evaluation of Macular Pigment Optical Density in Healthy Eyes Based on Dual-Wavelength Autofluorescence Imaging in South Indian Population" Transl. Vis. Sci. Technol. (2020) 10.1167/tvst.9.8.40
[38]
Davey "Differences in macular pigment optical density across four ethnicities: A comparative study" Ther. Adv. Ophthalmol. (2020) 10.1177/2515841420924167
[39]
(2021, March 16). Central Vision Analyzer. Available online: https://sinclairtechnologiesllc.com/project/real-world-functional-vision-analysis/cva/.
[40]
Wittich "Test-retest Variability of a Standardized Low Vision Lighting Assessment" Optom. Vis. Sci. (2018) 10.1097/opx.0000000000001275
[41]
Newsome "Reproducible measurement of macular light flash recovery time using a novel device can indicate the presence and worsening of macular diseases" Curr. Eye Res. (2009) 10.1080/02713680802647654
[42]
Loughman "Clinical applicability of the Macular Degeneration Detection Device (MDD-2): A novel photostress recovery measurement device" Clin. Exp. Optom. (2013) 10.1111/j.1444-0938.2012.00813.x
[43]
(2021, March 21). Brain Training That Works. Available online: https://www.brainhq.com/?v4=true&fr=y.
[44]
Holz, F.G., Schmitz-Valckenberg, S., Spaide, R.F., and Bird, A.C. (2007). Atlas of Fundus Autofluorescence Imaging, Springer. [1st ed.].
10.1007/978-3-540-71994-6
[45]
Xu, Q., Li, Y., Cheng, Y., and Qu, Y. (2018). Assessment of the effect of age on macular layer thickness in a healthy Chinese cohort using spectral-domain optical coherence tomography. BMC Ophthalmol., 18.
10.1186/s12886-018-0842-y
[46]
Chous "The Diabetes Visual Function Supplement Study (DiVFuSS)" Br. J. Ophthalmol. (2016) 10.1136/bjophthalmol-2014-306534
[47]
Loughman "Macular pigment response to lutein, zeaxanthin and meso-zeaxanthin supplementation in open angle glaucoma: A randomized controlled trial" Ophthalmol. Sci. (2021) 10.1016/j.xops.2021.100039
[48]
Siah "Macular pigment is associated with glare-affected visual function and central visual field loss in glaucoma" Br. J. Ophthalmol. (2018) 10.1136/bjophthalmol-2017-310215
[49]
Bone, R.A., Davey, P.G., Roman, B.O., and Evans, D.W. (2020). Efficacy of Commercially Available Nutritional Supplements: Analysis of Serum Uptake, Macular Pigment Optical Density and Visual Functional Response. Nutrients, 12.
10.3390/nu12051321
[50]
Broberg "Driving Characteristics of Older Drivers and Their Relationship to the Useful Field of View Test" Gerontology (2017) 10.1159/000448281
Showing 50 of 52 references
Metrics
12
Citations
52
References
Details
- Published
- Sep 14, 2021
- Vol/Issue
- 13(9)
- Pages
- 3191
- License
- View
Authors
Funding
ZeaVision LLC Chesterfield, MO USA NCT04741763 at (www.clinicaltrials.gov).
Award: ZeaVision LLC Chesterfield, MO USA NCT04741763 at (www.clinicaltrials.gov).
Cite This Article
Stuart Richer, Steven Novil, Taylor Gullett, et al. (2021). Night Vision and Carotenoids (NVC): A Randomized Placebo Controlled Clinical Trial on Effects of Carotenoid Supplementation on Night Vision in Older Adults. Nutrients, 13(9), 3191. https://doi.org/10.3390/nu13093191
Related
You May Also Like
The Firmicutes/Bacteroidetes Ratio: A Relevant Marker of Gut Dysbiosis in Obese Patients?
Fabien Magne, Martin Gotteland · 2020
1,958 citations
Effects of COVID-19 Home Confinement on Eating Behaviour and Physical Activity: Results of the ECLB-COVID19 International Online Survey
Achraf Ammar, Michael Brach · 2020
1,460 citations